Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-7732.21%
operating margin TTM
-8256.32%
revenue TTM
735.77 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -2.83 |
| peg ratio | -0.17 |
| price to book ratio | 2.86 |
| price to sales ratio | 220.60 |
| enterprise value multiple | -3.16 |
| price fair value | 2.86 |
profitability ratios | |
|---|---|
| gross profit margin | -1890.39% |
| operating profit margin | -8256.32% |
| pretax profit margin | -7732.21% |
| net profit margin | -7732.21% |
| return on assets | -74.09% |
| return on equity | -82.0% |
| return on capital employed | -107.63% |
liquidity ratios | |
|---|---|
| current ratio | 3.67 |
| quick ratio | 3.67 |
| cash ratio | 1.07 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 112.02 |
| days of payables outstanding | 250.09 |
| cash conversion cycle | -138.06 |
| receivables turnover | 3.26 |
| payables turnover | 1.46 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -45.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.57 |
| cash per share | 0.87 |
| operating cash flow per share | -0.57 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -45.58 |
| short term coverage ratios | -51.95 |
| capital expenditure coverage ratio | -861.89 |
Frequently Asked Questions
When was the last time Cardiff Oncology, Inc. (NASDAQ:CRDF) reported earnings?
Cardiff Oncology, Inc. (CRDF) published its most recent earnings results on 06-11-2025.
What is Cardiff Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cardiff Oncology, Inc. (NASDAQ:CRDF)'s trailing twelve months ROE is -82.0%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cardiff Oncology, Inc. (CRDF) currently has a ROA of -74.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CRDF's net profit margin stand at?
CRDF reported a profit margin of -7732.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CRDF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.67 in the most recent quarter. The quick ratio stood at 3.67, with a Debt/Eq ratio of 0.02.